
| |
|
Trimethylaminuria (TMAU),
also known as fish odor syndrome or fish malodor
syndrome, is a rare metabolic disorder that causes a
defect in the normal production of the enzyme Flavin
containing monooxygenase 3 (FMO3).[2][3] When FMO3 is
not working correctly or if not enough enzyme is
produced, the body loses the ability to properly
breakdown trimethylamine (TMA) from precursor compounds
in food into trimethylamine oxide (TMAO) through a
process called N-oxygenation. Trimethylamine then builds
up and is released in the person's sweat, urine, and
breath, giving off a strong fishy odor. |
|
|
|
 |

|
Clinical Research on Lamnitab |
| |
Lamnitab is clinically proven to
treat Trimethylaminuria successfully. You may download a summary of our
clinical study in Adobe's PDF format. Click
here for details.
|
|
|
Lamnitab
Guarantee |
| |
Lamnitab is a completely
guaranteed treatment. You are at no risk for trying Lamnitab. Click
here for details.
|
|
|